Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -20.800% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CCCCn1c(N)c(N(CCC)C(=O)C2CCCC2)c(=O)[nH]c1=O
b Nc1ccc(Cl)c(S(=O)(=O)Nc2ccccc2Cl)c1
c CCCNC(=S)N1CCC(NC(=O)c2ccc(OC)cc2)CC1
d COc1ccccc1C(=O)N(CCC1CCCN1C)c1nc2ccccc2s1
Answer: a. CCCCn1c(N)c(N(CCC)C(=O)C2CCCC2)c(=O)[nH]c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCCn1c(N)c(N(CCC)C(=O)C2CCCC2)c(=O)[nH]c1=O
CCCCn1c(N)c(N(CCC)C(=O)C2CCCC2)c(=O)[nH]c1=O
N-(6-amino-1-butyl-2,4-dioxopyrimidin-5-yl)-N-propylcyclopentanecarboxamide